A suggested approach to once-daily aminoglycoside dosing.
about
Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity.Dihydrostreptomycin or streptomycin in combination with penicillin G in dairy cattle therapeutics: a review and re-analysis of published data. Part 1: clinical pharmacology."Random" gentamicin concentrations do not predict trough levels in neonates receiving once daily fixed dose regimens.Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) studyThe therapeutic monitoring of antimicrobial agents.Simplified equations using two concentrations to calculate area under the curve for antimicrobials with concentration-dependent pharmacodynamics: daptomycin as a motivating exampleAntifungal Amphiphilic AminoglycosidesUsing population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations.How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?The performance of contemporary cystatin C-based GFR equations in predicting gentamicin clearance.Administration of aminoglycosides to hemodialysis patients immediately before dialysis: a new dosing modalityTherapeutic drug monitoring of antimicrobials.Development of a dosing strategy for enoxaparin in obese patients.Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.Comparison of gentamicin dose estimates derived from manual calculations, the Australian 'Therapeutic Guidelines: Antibiotic' nomogram and the SeBA-GEN and DoseCalc software programsPharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.Evaluation of serum concentrations achieved with an empiric once-daily tobramycin dosage regimen in children and adults with cystic fibrosis.How aminoglycosides are used in critically ill patients in a teaching hospital in North of IranIndividualized drug and dose: the clinical pharmacologist's calling or curse?Mitochondrial deafness alleles confer misreading of the genetic codeTarget concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic studyInfluence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing.Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patientsBayesian Estimation of Tobramycin Exposure in Patients with Cystic Fibrosis.Therapeutic drug monitoring of aminoglycosides in neonates.Understanding and overcoming aminoglycoside resistance caused by N-6'-acetyltransferase.Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.Tobramycin pharmacokinetics in patients with cystic fibrosis before and after bilateral lung transplantation.Comparison of mortality between nosocomial and community-acquired febrile neutropenia patients treated initially with cefazolin plus tobramycin: retrospective chart review.Pharmacological considerations for the proper clinical use of aminoglycosides.Metabolic and toxicological considerations for sepsis drug treatments.Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.Drug-induced renal Fanconi syndrome.Pharmacokinetics and pharmacodynamics in antibiotic dose optimization.Therapeutic drug monitoring of anti-infective agents in critically ill patients.Comparing dosage adjustment methods for once-daily tobramycin in paediatric and adolescent patients with cystic fibrosis.Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins.Multidrug Resistant Pseudomonas Mycotic Pseudoaneurysm following Cardiac Transplant Bridged by Ventricular Assistant Device.Extended-interval gentamicin administration in neonates: a simplified approach.
P2860
Q30488706-0FC25A04-8E51-4611-879F-0A0B7176E0CBQ30995411-6812C134-39F3-4812-8487-22C2BC494E5DQ33236907-2BE576CC-0B4B-432A-8DEF-25E741CEC40AQ33518061-0E68C756-1D6F-4A8F-AB97-0BF565200A8AQ33540451-3380BFDC-B03E-45B1-810C-9D6FDDBD0C87Q33798143-1873D2E6-4168-4F97-B0A7-A8B162920538Q34015337-2F6C5A4D-FF51-458D-95FE-F5A7F796BFF8Q34108507-2791788B-4C4F-4AD5-B8C7-8893DDF2AE3EQ34476089-741A610B-8D99-4A4C-B064-BA0EFE81F068Q34894900-50FE30D4-4A5D-4DB5-9BE7-3A02CA0F59FCQ35023720-378FFE39-9A5D-48D5-86BF-AD94D1F47C6BQ35139187-52C104F8-455A-4C33-A19F-1FBE65947A83Q35640430-3B17A4CA-2515-4D98-B4D9-8C48083E4BA6Q35825624-C3B5BE17-28AE-4C53-9584-01475436DC98Q35826231-0427F2F6-2B07-4CD5-B171-8CAC5C9F46C5Q35826457-9C7E5508-C658-47DA-B9D6-9F6F221FFA5EQ36053463-A07603C9-BFA1-4E27-95AD-636D7C77C552Q36191093-CEE5E275-2833-4791-BC19-4E3CD4E7CFDBQ36290910-7306B704-4628-4743-AF1E-4988B9D0A47CQ36365374-FDFBE40C-0DE9-4A00-AF42-BB1DFE133886Q36491293-2AB9F2BD-C74C-4EB0-AFDB-36708138BE0AQ36536423-AE35CFD2-AFEC-445A-B051-F64678AD14EEQ36666776-B8401CCD-257C-4FD2-8F02-F46B6C7F2831Q37011672-CAA234C1-816C-4F59-9E3A-6085F93CE31EQ37358664-A78FA71D-41ED-404B-829E-6563243275C4Q37409465-6C39CA36-968F-484A-B9C1-F8769D9D818AQ37528001-6728DC74-A67F-4E68-8FE9-352D121EDC90Q37661501-8D8021ED-8742-4FCA-A5A0-5AA6FBA0EC17Q37906783-DB19910B-5AFE-4FC7-95F8-55680B42FBB1Q37942767-09FD638D-8A17-47A3-A684-E214264A3EB4Q37956403-57FA48C8-545A-4A95-85BC-708D935244F2Q38045406-288A57F5-9850-4FE0-B1E5-17BC1DEA988FQ38090988-BF7116AB-7F01-460F-BE84-A4997D03577CQ38173853-A5027062-596F-4413-92EC-4944CB647E96Q38664871-6E7AD61D-BF2D-4FE4-B5AD-82E94E73FA24Q38790740-6BCCCB29-3D0B-405A-908E-727B175EF6A9Q39097052-10F7EECB-6DCB-4702-9E26-73A4018EE7BDQ39849790-211638E1-2876-40FC-A40E-4828F8718B27Q40261115-A33FD6E8-02FD-41EA-B395-EFE4A82AA7C5Q40751575-75122D68-D215-4A2F-B802-85C4F66DC46F
P2860
A suggested approach to once-daily aminoglycoside dosing.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
A suggested approach to once-daily aminoglycoside dosing.
@ast
A suggested approach to once-daily aminoglycoside dosing.
@en
A suggested approach to once-daily aminoglycoside dosing.
@nl
type
label
A suggested approach to once-daily aminoglycoside dosing.
@ast
A suggested approach to once-daily aminoglycoside dosing.
@en
A suggested approach to once-daily aminoglycoside dosing.
@nl
prefLabel
A suggested approach to once-daily aminoglycoside dosing.
@ast
A suggested approach to once-daily aminoglycoside dosing.
@en
A suggested approach to once-daily aminoglycoside dosing.
@nl
P2093
P2860
P1476
A suggested approach to once-daily aminoglycoside dosing.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1995.TB05719.X
P407
P577
1995-06-01T00:00:00Z